uniQure (QURE) Competitors

Biohaven (NYSE:BHVN) and uniQure (NASDAQ:QURE) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability, community ranking and analyst recommendations.

Do analysts rate BHVN or QURE?

Biohaven currently has a consensus price target of $63.15, suggesting a potential upside of 111.93%. uniQure has a consensus price target of $38.89, suggesting a potential upside of 170.81%. Given uniQure's higher probable upside, analysts plainly believe uniQure is more favorable than Biohaven.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biohaven	0 Sell rating(s)	0 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	3.07
uniQure	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.80

Is BHVN or QURE more profitable?

Biohaven has a net margin of 0.00% compared to uniQure's net margin of -837.80%. uniQure's return on equity of -188.82% beat Biohaven's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biohaven	N/A	-225.12%	-158.89%
uniQure	-837.80%	-188.82%	-32.17%

Does the MarketBeat Community prefer BHVN or QURE?

uniQure received 250 more outperform votes than Biohaven when rated by MarketBeat users. Likewise, 70.54% of users gave uniQure an outperform vote while only 67.44% of users gave Biohaven an outperform vote.

Company	Underperform	Outperform
Biohaven	Outperform Votes 406 67.44%	Underperform Votes 196 32.56%
uniQure	Outperform Votes 656 70.54%	Underperform Votes 274 29.46%

Which has stronger valuation and earnings, BHVN or QURE?

uniQure has higher revenue and earnings than Biohaven. Biohaven is trading at a lower price-to-earnings ratio than uniQure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biohaven	N/A	N/A	-$408.17M	-$9.39	-3.17
uniQure	$27.12M	28.63	-$308.48M	-$4.93	-2.91

Do institutionals and insiders believe in BHVN or QURE?

88.8% of Biohaven shares are held by institutional investors. Comparatively, 78.8% of uniQure shares are held by institutional investors. 16.0% of Biohaven shares are held by insiders. Comparatively, 4.7% of uniQure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Which has more volatility & risk, BHVN or QURE?

Biohaven has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, uniQure has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500.

Does the media prefer BHVN or QURE?

In the previous week, Biohaven had 2 more articles in the media than uniQure. MarketBeat recorded 4 mentions for Biohaven and 2 mentions for uniQure. Biohaven's average media sentiment score of 0.69 beat uniQure's score of 0.00 indicating that Biohaven is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biohaven	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
uniQure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

uniQure beats Biohaven on 9 of the 17 factors compared between the two stocks.